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Accepted 26 January 2011We present a successful pregnancy in a woman with
hydrosalpinx and hydrometra after hydrosalpinx aspiration
during oocyte collection in the in vitro fertilization (IVF)
cycle. To our knowledge, this is the first report to combine
ultrasound-guided hydrosalpinx aspiration with a mouse
embryo assay of hydrosalpinx fluid for selection of appropriate
treatment options for women with both hydrosalpinx and
hydrometra. This new strategy provides valuable information
to clinicians so that a more rational decision can be made to
either go ahead with the cycle or to freeze all embryos and
consider the possibility of surgical treatment.
A 33-year-old nullipara was involved in our IVF program
because of tubal factor infertility. She had received tuboplastic
surgery elsewhere for bilateral tubal obstruction 10 years
previously. A hysterosalpingogram revealed bilateral tubal
obstruction with left hydrosalpinx (Fig. 1A). Before ovarian
stimulation, a baseline transvaginal ultrasound revealed no
visible hydrosalpinx or any fluid in the uterine cavity. The
ovarian stimulation protocol was performed as previously
described [1]. Left hydrosalpinx was first recognized from
cycle day 7 and had increased in size with ovarian stimulation
(Fig. 1B). Serum estradiol levels on the day of human cho-
rionic gonadotropin (hCG) administration and the day of
oocyte retrieval were 1832 and 2197 pg/mL, respectively.
Endometrial fluid collection was first recognized after hCG
administration and reached a maximum diameter of 15 mm at
the time of oocyte retrieval (Fig. 1C). Ten oocytes were
retrieved transvaginally, and then 12 mL of clear fluid was
aspirated from left hydrosalpinx until it collapsed completely.
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mouse embryo assay, as previously described [1]. The blasto-
cyst development rate on day 3 was used to calculate a blas-
tulation index: Blastulation index ¼ percentage blastocyst
development rate of test/percentage blastocyst development
rate of the control. A blastulation index of less than 0.5 was
considered to be potentially embryotoxic, while an index of 1.0
or higher was consider to be embryotrophic. The blastulation
indices of 10, 50, and 100% of hydrosalpinx fluid were 1.37,
1.13, and 1.04, respectively. Analysis of the hydrosalpinx fluid
revealed levels of sodium of 135 mmol/L, potassium of
3.6 mmol/L, chloride of 118 mmol/L, calcium of 0.14 mmol/L,
glucose of 18 mg/dL, lactate of 2.2 mmol/L, bicarbonate of
28.2 mmol/L, and total protein of 1.6 g/dL; a pH of 7.56; and
osmolality of 261 mOsmol/kg. We also analyzed human tubal
fluid (HTF) medium, which is utilized routinely in our daily
IVF program as control. Analysis of the HTF medium revealed
levels of sodium of 138 mmol/L, potassium of 4.1 mmol/L,
chloride of 108 mmol/L, calcium of 0.71 mmol/L, glucose of
51 mg/dL, lactate of 10.9 mmol/L, bicarbonate of 21.4 mmol/L,
and total protein of 0 g/dL; a pH of 7.42; and osmolality of
269 mOsmol/kg. Transvaginal ultrasound 48 h after oocyte
retrieval showed that the endometrial fluid had reduced to 5
mm in diameter (Fig. 1D). In view of decreasing endometrial
fluid collection, we decided to perform embryo transfer instead
of cryopreservation of all resulting embryos. Four good quality
embryos were transferred to the uterine cavity on day 3. An
ultrasound was performed 7 days later, which revealed no
endometrial fluid collection and hydrosalpinx. A singleton
pregnancy was established and the woman vaginally delivered
a female baby weighing 3162 g at 39 weeks of gestation.
Hydrosalpinges have adverse effects on IVF outcome.
The proposed mechanisms to explain the adverse effects
of hydrosalpinges include a direct embryotoxic effect [2],cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) Hysterosalpingogram shows bilateral obstruction with left hydrosalpinx. (B) Transvaginal ultrasound on cycle day 12 demonstrates enlarging
hydrosalpinx. (C) Endometrial fluid collection on the day of oocyte retrieval. (D) Endometrial fluid collection before embryo transfer. Note that endometrial fluid
had reduced remarkably after aspiration of hydrosalpingeal fluid.
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that tubal fluid might mechanically flush the embryo from the
uterus [4].
When hydrosalpinges are presented before IVF treatment is
initiated, surgical excision, drainage, or proximal ligation of
the hydrosalpinx have been reported to increase the success
rate [5]. Table 1 summarizes the published papers of women
who developed hydrosalpinx and hydrometra during IVF
cycles. The rate of hydrosalpinx with hydrometra varies from
3.1% to 7.8%. [6e9]. Hydrosalpinx patients with documented
uterine reflux possibly have the worst prognosis. For these
patients, freezing of the resulting embryos followed by surgical
correction of hydrosalpinx should be considered [10e12]. A
recent study by He et al [13] found that none of the 11 patientsTable 1
Published papers of women who developed hydrosalpinx and hydrometra
during IVF cycles.
Year Author Number of
patients with
hydrosalpinx
Number of
patients with
hydrosalpinx
and hydrometra
Number of
clinical
pregnancies
1991 Mansour et al [4] 3 3 0
1996 Andersen et al [6] 38 3 (7.8%) 0
1997 Bloechle et al [10] 1 1 0
1997 Sharara et al [12] 2 2 0
2001 Levi et al [9] 71 5 (7.0%) 2*
2002 Chien et al [7] 142 8 (5.6%) 0
2008 Hammadieh et al [8] 32 1 (3.1%) 0
Total 289 23 2
* Both hydrosalpinx and hydrometra were presented. Endometrial cavity
fluid was seen only after the administration of human chorionic gonadotropin.with endometrial cavity fluid of 3.5 mm or higher in ante-
rioreposterior diameter on the day of oocyte retrieval
conceived. However, even in patients without hydrosalpinx,
fluid accumulation can occur in the uterine cavity. Lee et al [14]
reported that clinical pregnancy was not compromised if the
endometrial cavity fluid was not from hydrosalpinx. Aspiration
of uterine fluid seems to be ineffective, because there is a rapid
re-accumulation of hydrometra [11].
For women who do not present hydrosalpinx on initial
ultrasound, but who do so after ovarian stimulation, the deci-
sion making for such condition is more difficult. Ultrasound-
guided aspiration of hydrosalpinx at oocyte collection is an
option for women who develop hydrosalpinx during controlled
ovarian stimulation. A recent randomized controlled study
observed that clinical pregnancies occurred in 31.3% (10 of 32)
of women after aspiration and 17.6% (6 of 34) of women
without aspiration (relative risk¼ 1.8, p¼ 0.2) [8]. The authors
found that the re-accumulation of the fluid is unlikely to
develop rapidly enough to prevent the implantation or preg-
nancy. Aspiration of hydrosalpinx may reduce the endometrial
fluid collection by decreasing the reflux of tubal fluid into
endometrial cavity. However, recurrence of both hydrosalpinx
and hydrometra after transvaginal aspiration of tubal fluid has
been reported [10,11]. Recurrence of hydrosalpinx with the
development of large hydrometra after aspiration of tubal fluid
possibly has the worst prognosis. The clinician should consider
freezing the resulting embryos and follow by surgical correc-
tion of hydrosalpinx prior to cryotransfer [7,9e12].
Cryopreservation with thaw transfer after salpingectomy or
tubal ligation might be a better option for this case if we did
not perform hydrosalpinx aspiration and mouse embryo assay
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aspiration at the time of oocyte retrieval would be the simplest
method of treating both hydrosalpinx and hydrometra. Aspi-
ration of hydrosalpinx fluid appears to reduce the amount of
endometrial fluid accumulation, which is a favorable prog-
nostic sign for successful implantation.
Themouse embryo assay of hydrosalpinx fluid is a useful tool
to test the embryotoxicity of hydrosalpinx fluid [2]. The effect of
hydrosalpinx fluid on embryo development and implantation has
been examined in several studies and was summarized in
a review [15], but findings were not consistent. Five out of eight
studies described a toxic effect on mouse embryos at low
concentrations of hydrosalpnx fluid, and three studies demon-
strated impaired development only in undiluted hydrosalpinx
fluid. Our previous study has shown the heterogeneous nature of
hydrosalpinx fluid [1]. We demonstrate that the mouse embryo
assay of hydrosalpinx fluid may be useful in selection of
appropriate treatment options for patients with hydrosalpinx
who are undergoing IVF treatment [1]. The present case report
further demonstrates that newly formed tubal fluid during
ovarian stimulation does not seem to be embryotoxic, and
successful implantation could be achieved despite the presence
of a small amount of endometrial fluid before embryo transfer.
However, detailed follow-up studies are required to ascertain the
reliability and feasibility of this proposed strategy.
Cancellation of the treatment cycle or cryopreservation of
resulting embryos should only be considered for those patients
who developed persistent large hydrometra despite the aspi-
ration of tubal fluid [10,11]; fortunately this is an infrequent
condition. In addition, transvaginal aspiration at the time of
oocyte collection and sclerotherapy with 98% ethanol can be
used as a new alternative treatment option for patients who
decide to cancel the current treatment cycle [16].References
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